Today’s Research Reports on Trending Tickers: Sophiris Bio and Achaogen

NEW YORK, NY / ACESSWIRE / June 26, 2018 / U.S. equities plunged on Monday, as indexes posted their biggest one-day decline in week, as fresh threats from President Trump added to the uncertainties of a potential trade war. The S&P 500 Index shed 1.37 percent to close at 2,717.07, while the Nasdaq Composite dropped 2.09 percent to close at 7,532.01. The Dow Jones Industrial Average declined 1.33 percent to settle at 24,252.80, its lowest close since May 4.

“You can now make the case that we’re in a trade war. The language has gotten bad enough, companies are saying the issue is impacting them, and there’s a sense that the numbers and scope of the issue are ratcheting up,” said Willie Delwiche, investment strategist at Robert W. Baird.

RDI Initiates Coverage on:

Sophiris Bio, Inc.
https://rdinvesting.com/news/?ticker=SPHS

Achaogen, Inc.
https://rdinvesting.com/news/?ticker=AKAO

Sophiris Bio’s stock moved 40.27% lower Monday, to close the day at $2.24. The stock recorded a trading volume of 4,981,665 shares, which was above its three months average volume of 405,847 shares. In the last year, Sophiris Bio’s shares have traded in a range of 1.80 – 4.05. The share price has gained 24.44% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $3.51 is above its 200-day moving average of $2.53. Shares of Sophiris Bio have fallen roughly 37.08 percent in the past month and are down 1.32 percent year-to-date.

Access RDI’s Sophiris Bio, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SPHS

On Monday, shares of Achaogen recorded a trading volume of 1,064,552 shares, which was below the three months average volume of 1,177,465 shares. The stock ended the day 3.22% lower at $12.02. The share price has fallen 52.34% from its 52 week high with a 52 week trading range of 9.83 – 25.22. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $12.26 is above its 200-day moving average of $11.78. Shares of Achaogen have fallen roughly 1.23 percent in the past month and are up 11.92 percent year-to-date.

Access RDI’s Achaogen, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AKAO

Our Actionable Research on Sophiris Bio, Inc. (NASDAQ :SPHS) and Achaogen, Inc. (NASDAQ :AKAO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 503766